Safety of a Ready to Drink Supplement
NB10
Short-Term Safety and Dose Effects of a Ready to Drink Pre-Workout Supplement
1 other identifier
interventional
28
0 countries
N/A
Brief Summary
This study will examine a Ready to Drink (RTD) supplement.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2016
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2016
CompletedFirst Submitted
Initial submission to the registry
January 20, 2017
CompletedFirst Posted
Study publicly available on registry
January 26, 2017
CompletedJanuary 26, 2017
January 1, 2017
8 months
January 20, 2017
January 23, 2017
Conditions
Outcome Measures
Primary Outcomes (3)
The effects of ingesting an RTD immediately prior to exercise on the blood
7 days
The effects of ingesting an RTD immediately prior to exercise on heart rate
7 days
The effects of ingesting an RTD immediately prior to exercise on blood pressure
7 days
Secondary Outcomes (1)
The effects of ingesting an RTD immediately prior to exercise on self-reported side effects
7 days
Study Arms (2)
RTD
EXPERIMENTAL2.1 g. beta alanine, 1.3 g arginine nitrate, 200 mg caffeine, 65 mg niacin, 325 mcg folic acid, 45 mcg vitamin B12
Placebo
PLACEBO COMPARATORdextrose and non-caloric flavoring
Interventions
Eligibility Criteria
You may qualify if:
- Participants are apparently healthy and recreationally active males and females between the ages of 18 and 40
You may not qualify if:
- Participants are under 18 years old and above 40 years old
- Participants have a history of treatment for metabolic disease (i.e., diabetes), hypertension, hypotension, thyroid disease, arrhythmias and/or cardiovascular disease
- Participants currently use any prescription medication (birth control is allowed)
- Participants are pregnant or lactating females or plan to become pregnant within the next month
- Participants have a history of smoking
- Participants drink excessively (12 drinks per week or more)
- Participants have a recent history of creatine supplementation within 8 weeks of the start of supplementation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Officials
- PRINCIPAL INVESTIGATOR
Richard B Kreider, PhD
Texas A&M University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 20, 2017
First Posted
January 26, 2017
Study Start
January 1, 2016
Primary Completion
September 1, 2016
Study Completion
September 1, 2016
Last Updated
January 26, 2017
Record last verified: 2017-01
Data Sharing
- IPD Sharing
- Will not share